Alva Strand as our new scientist

We are excited to introduce Alva Strand, who joins our team at SampleFacts as a Scientist.
Alva holds a degree in Biomedical Laboratory Sciences and a master’s in Medical Research from Uppsala University, bringing a robust academic background and deep expertise to our team. Her experience and dedication to advancing medical research align seamlessly with our mission at SampleFacts.
Alva’s journey is defined by her resilience and innovative mindset, qualities that make her an exceptional addition to our growing team. Her passion for impactful research will undoubtedly contribute to shaping our projects and driving scientific breakthroughs.
Please join us in welcoming Alva to the SampleFacts family! We look forward to her inspiring contributions and collaborative spirit as we continue to innovate and grow together.
Frida Ekholm as our new Vice President of R&D

We are excited to introduce Frida Ekholm, who joins our team at SampleFacts as the Vice President of Research and Development.
Frida brings over two decades of experience in immunology and scientific innovation, with a rich background in T cell research, Alzheimer’s disease diagnostics, and antibody development. During her PhD, she made significant strides in enhancing our understanding of immune responses, followed by leading groundbreaking Alzheimer’s research focused on monoclonal antibodies.
Frida’s career also includes over 12 years at Thermo Fisher Scientific in their Immunodiagnostic Division (IDD), where she played a key role in driving scientific advancements and leading complex projects. Her leadership, experience, and passion for advancing research will be instrumental in shaping the future of our R&D efforts at SampleFacts. We are thrilled to have Frida on our team and look forward to her contributions!
Please join us in welcoming Frida to the SampleFacts family!
Maryam Poorafshar as new CEO

SampleFacts announces the appointment of Maryam Poorafshar as Chief Executive Officer
SampleFacts AB today announced the appointment of Maryam Poorafshar as Chief Executive Officer. With more than 20 years of experience within the life sciences, Maryam has held leading roles in Research and Development, Product launch Projects, Medical and Clinical Affairs and KOL management, serving most recently as Executive Vice President R&D in Biotage AB. Prior to joining Biotage, Maryam held several senior roles in Thermo Fisher Scientific. She has a Ph.D. in molecular immunology from Uppsala University and an Executive MBA from M-gruppen.
SampleFacts moves in to new offices

SampleFacts are moving into new offices at the BMC building of Uppsala university.
Ulf Landegren presents at BioScience 2023

Ulf Landegren presents at BioScience 2023
Professor Ulf Landegren presents SampleFacts at BioScience 2023. Professor Ulf Landegren speaks about SampleFacts innovative blood separating sampling cards at the bioscience event 2023 by Life Science Sweden.
MedTech magazine Interview

MedTech magazine Interviews founder and CEO of SampleFacts Nina Schiller. Read the article here.
Molecular Diagnostics workshop in Kenya

SampleFacts is presented at the Molecular Diagnostics workshop in Kenya.
SampleFacts is presented at a three day workshop at the Molecular Diagnostics workshop in Naivasha, Kenya. Professor Dr. Masood Kamali-Moghaddam and Dr. Radiosa Gallini from the department of immunology, genetics and phatology/molecular tools at Uppsala university highlighted SampleFacts at both the workshop and the conference.
Attractive Innovation Project Award 2023

SampleFacts receives “Attractive Innovation Project Award 2023”.
Uppsala University Innovation awards startup companies that have made technological advancements and also have successfully attracted external funding. SampleFacts was awarded Uppsala University Innovation’s “Attractive Innovation Project Award 2023”.
Uppsala university Innovation Interviews founder






